HOME › COVERAGE › OTLK
COVERAGE HUB
$OTLK
1 articles in last 30 days
LAST 30 DAYS
1 articles
AVG GRADE
HIGH
score: 1.00
SENTIMENT
NEUTRAL
TOTAL VIEWS
1
RECENT COVERAGE · 1 ARTICLES
seekingalpha.com · 15:12 · 06/18 HIGH
Outlook Therapeutics Heads Into Another FDA PDUFA Decision For Lytenava (NASDAQ:OTLK)
Outlook Therapeutics (OTLK) faces a pivotal binary FDA catalytic event with the July 29 PDUFA decision for its therapy candidate...
NEWS-BASED SECTOR EXPOSURE ANALYSISPOWERED BY CLAUDE HAIKU 4.5NOT INVESTMENT ADVICE